Produktinformation
The Zika virus NS1 antibody is a monoclonal antibody that specifically targets the virus surface antigen. It has been shown to have cytotoxic effects by inducing the production of tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ), which are important in the immune response against viral infections. This antibody also has neutralizing properties, meaning it can block the activity of the Zika virus and prevent its replication. In addition to its antiviral effects, the Zika virus NS1 antibody has been found to inhibit interleukin-6 (IL-6) production, which is involved in inflammation. This suggests that it may have anti-inflammatory activities as well. Furthermore, this monoclonal antibody has been shown to bind to MERTK, a protein kinase that plays a role in cell signaling and immune regulation. By targeting MERTK, the Zika virus NS1 antibody may help regulate immune responses and enhance the body's ability to fight against viral infections.